alprazolam has been researched along with Fatigue in 4 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
Fatigue: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.
Excerpt | Relevance | Reference |
---|---|---|
"In a multicenter placebo-controlled study, the safety, side effects, and patient acceptance of alprazolam for the treatment of panic disorder and agoraphobia were examined." | 9.06 | Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. ( Ballenger, JC; Burrows, GD; DuPont, RL; Noyes, R; Pecknold, JC; Rifkin, A; Rubin, RT; Swinson, RP, 1988) |
"In a multicenter placebo-controlled study, the safety, side effects, and patient acceptance of alprazolam for the treatment of panic disorder and agoraphobia were examined." | 5.06 | Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. ( Ballenger, JC; Burrows, GD; DuPont, RL; Noyes, R; Pecknold, JC; Rifkin, A; Rubin, RT; Swinson, RP, 1988) |
"Buspirone was compared to alprazolam and lorazepam in the treatment of generalized anxiety disorder in a 4-week, double-blind study of 60 patients." | 2.66 | Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study. ( Cohn, JB; Wilcox, CS, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mills, KC | 1 |
Spruill, SE | 1 |
Kanne, RW | 1 |
Parkman, KM | 1 |
Zhang, Y | 1 |
Newton, RE | 1 |
Marunycz, JD | 1 |
Alderdice, MT | 1 |
Napoliello, MJ | 1 |
Cohn, JB | 1 |
Wilcox, CS | 1 |
Noyes, R | 1 |
DuPont, RL | 1 |
Pecknold, JC | 1 |
Rifkin, A | 1 |
Rubin, RT | 1 |
Swinson, RP | 1 |
Ballenger, JC | 1 |
Burrows, GD | 1 |
1 review available for alprazolam and Fatigue
Article | Year |
---|---|
Review of the side-effect profile of buspirone.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as T | 1986 |
4 trials available for alprazolam and Fatigue
Article | Year |
---|---|
The influence of stimulants, sedatives, and fatigue on tunnel vision: risk factors for driving and piloting.
Topics: Alcohol Drinking; Alprazolam; Analysis of Variance; Automobile Driving; Aviation; Central Nervous Sy | 2001 |
Review of the side-effect profile of buspirone.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as T | 1986 |
Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; C | 1986 |
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Ataxia; Chemical and Drug Induced Liver Injury; F | 1988 |